Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Amniotic membrane is the innermost layer of fetal membrane which is extracted from placenta of women and harvested to be used as a transplant material for reconstructive surgery for cases such as severely burnt skin, trauma wounds, chronic wounds and others. Amniotic membrane was initially used as a substrate for skin graft (skin transplantation surgery). According to the National Centre of Biotechnology Information (NCBI), amniotic membranes can also be used in a variety of applications such as ophthalmic surgery, cosmetic surgery, anticancer treatment, and as a regenerative medicine. Use of amniotic membrane is preferred due to its non-immunogenicity, anti-scarring property, antimicrobial property, and ability to reduce inflammation.

Global Amniotic Membrane Market - Impact of the Coronavirus (COVID-19) Pandemic

Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 169 million cases and 3.5 million deaths due to coronavirus disease (COVID-19) were reported till May 30, 2021, across the globe.

Impact of COVID-19 on Demand and Supply of Amniotic Membrane

The COVID-19 pandemic and lockdown in various countries across the globe have impacted the financial status of businesses across all sectors including private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions. The COVID-19 pandemic has affected the economy of various regions across the globe in three main ways; 1) by directly affecting the production and demand; 2) by creating disruptions in distribution channels; and 3) through its financial impact on companies and financial markets. Many countries such as Thailand, Indonesia, and Singapore are facing problems with regards to transportation and distribution of healthcare products.

Thus, impact of the coronavirus (COVID-19) pandemic is expected to limit the growth of the global amniotic membrane market during the forecast period, owing to the decrease in the supply of healthcare products, suspension of ophthalmological surgery and risk of positive COVID-19 cases associated with amniotic membrane. For instance, according to an article published in the Nature scientific journal on June, 2020, amniotic membrane of COVID-19 positive females were tested to be positive for COVID-19 infection. Hence, the article suggests medical practitioners to carry out COVID-19 testing of asymptomatic amniotic membrane donors.

Also, COVID-19 pandemic resulted in a halt of ophthalmology procedures due to which the demand of amniotic membrane decreased. According to data provided by the National Centre for Biotechnology Information (NCBI), in case if ophthalmological surgeries are suspended for 2 years due to COVID-19 pandemic, over 1.1 million cases of ophthalmological surgery are estimated to be at halt in Monte Carlo wherein the patients have registered for ophthalmological surgery but the surgery has not been performed yet due to suspension of surgeries in view of the pandemic. This is expected to hamper the growth of amniotic membrane market.

The global amniotic membrane market is estimated to be valued at US$ 3,201.1 Mn in 2021, and is expected to exhibit a CAGR of 12.8% over the forecast period (2021-2028).

Figure 1: Global Amniotic Membrane Market Share (%) Analysis, By Product Type, 2021

 Amniotic Membrane  | Coherent Market Insights

The increasing number of ophthalmology & cosmetic surgeries is the major factor that is expected to drive the market growth over the forecast period.

Large numbers of ophthalmology and cosmetic surgery procedures are adopted by people all around the world, this is expected to bolster the growth of global amniotic membrane market. According to the American Society of Plastic Surgeons report, over 2.3 million cosmetic surgery procedures and over 6.8 million reconstructive procedures were carried out in U.S. in 2020.

Rising geriatric population also aids the growth of amniotic membrane market as majority of ophthalmological disorders are diagnosed in older population. According to the National Center for Biotechnology Information (NCBI) report 2020, over 800,000 cataract surgeries are performed every year in Germany and the frequency of these surgeries is seen to be increasing with growing age. The frequency of cataract surgeries is reported to be approximately 26% for age group 70 years and above.

request-sample

Amniotic Membrane Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 3,201.1 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 12.8% 2028 Value Projection: US$ 7,438.2 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Amniotic Membranes (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes), Amniotic Suspensions
  • By Application: Wound Care, Orthopedics, Ophthalmology, Others
  • By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research and Academic Institutes
Companies covered:

Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical

Growth Drivers:
  • Increasing Amniotic Membrane Applications
  • Rising Geriatric Population
  • Increasing Research and Development Activities by the Market Players
  • Increasing Product Launches and Approvals
Restraints & Challenges:
  • High cost of treatment 
  • Challenges related to use of amniotic membrane 

Research and Development activities

Increasing number of research and development activities for improving the efficacy of amniotic membrane and development of new products is expected to aid in the growth of the amniotic membrane market over the forecast period. For instance, in November 2020, Amnio Technology, an American regenerative medicine company, initiated Phase II clinical trials for testing the efficacy of their product PalinGen, which is an amniotic membrane allograft used for treating diabetic ulcers.

Increasing applications of amniotic membrane is expected to fuel the growth of market over the forecast period. Amniotic membrane finds its applications in a variety of sectors such as wound care, ophthalmology, orthopedics, and others. For instance, AlloSource, an American non-profit organization, provides AlloSkin skin graft which is useful in reconstructive procedures and cosmetic surgery. Moreover, Geistlich Derma-Gide, manufactured by Geistlich Pharma AG, an American regenerative medicine company, is a porous 3-D matrix used in wound management.

Global Amniotic Membrane Market – Restraints

However, growth of the amniotic membrane market may be hampered due to high cost associated with the treatment as well as due to challenges associated with user-friendliness of the amniotic membrane treatment. According to the Review of Optometry’s article published in January 2017, poor insertion or removal of an amniotic membrane transplant can result in corneal abrasion moreover, patient intolerance to some components of amniotic membrane formulations also limits the use of amniotic membranes.

Global Amniotic Membrane Market – Regional Analysis

On the basis of region, the global amniotic membrane market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold dominant position in the global amniotic membrane market over the forecast period, owing to the number of product launches. For instance, in September 2017, Amnio Technology launched PalinGel, which is an amniotic fluid derived allograft used in wound care for the purpose of supporting damaged soft tissues. Moreover, rising geriatric s of people falling in the age group of 60 years and above is estimated to reach 1.3 billion in Asia-Pacific region by 2050.

Figure 2: Global Amniotic Membrane Market Value (US$ 1203.6 Mn), by Region, 2021

Amniotic Membrane  | Coherent Market Insights

Global Amniotic Membrane Market – Competitive Landscape

Major players operating in the global amniotic membrane market include Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical

Amniotic membrane is an avascular layer of fetal membrane which can be extracted from placenta and stored in a sterile environment right after collection. It can be efficiently used in surgical procedures and in the treatment of ocular diseases or disorders such as ligneous conjunctivitis, corneal disease, etc. as well as for treating tissue damage. An amniotic membrane transplant (AMT) can be done using traditional suture and fibrin glue approach or by an advanced suture-less approach as well. AMT can be used to protect damaged tissues, stimulate growth of new cells, and reduce inflammation and pain by decreasing friction in the eyelids. According to a study published by the National Center for Biotechnology Information (NCBI) in February 2021, 94.3% of people who had undergone amniotic membrane transplant reported of healed epithelial defects while 88% people reported symptomatic relief from symptoms such as dryness, discomfort and pain.

Market Dynamics

Market players are focused on research and development activities to obtain approvals for novel products or techniques associated with amniotic membrane, this could contribute to the growth of the market over the forecast period. For instance, in 2018, MiMedx, an American biomedical company received the status of Regenerative Medicine Advanced Therapy (RMAT) by the U.S. Food and Administration for its product AmnioFix, an amniotic membrane that is designed for use in osteoarthritis treatment.

Market players are focusing on product launches, which is expected to strengthen their position in the global market. For instance, on February, 2020, Integra LifeSciences, an American medical technology company launched AmnioExcel Plus amniotic membrane that helps in wound care.

Market players are involved in expanding their global presence by adopting strategies such as acquisitions and partnerships, this is expected to drive the growth of the amniotic membrane market globally. For instance, in 2017, Organogenesis Holdings Inc., an American regenerative medicine company acquired NuTech Medical, an American biologics company, to expand their company product portfolio and support the development of next generation amniotic membrane products.

Key features of the study:

  • This report provides an in-depth analysis of global amniotic membrane market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global amniotic membrane market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global amniotic membrane market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the amniotic membrane market

Detailed Segmentation:

  • Global Amniotic Membrane Market, By Product Type:
    • Amniotic Membranes
    • Cryopreserved Amniotic Membranes
    • Dehydrated Amniotic Membranes
    • Amniotic Suspensions
  • Global Amniotic Membrane Market, By Application:
    • Wound Care
    • Orthopedics
    • Ophthalmology
    • Others
  • Global Amniotic Membrane Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics
    • Research and Academic Institutes
  • Global Amniotic Membrane Market, By Region:
    • North America
      • By Product Type:
        • Amniotic Membranes
        • Cryopreserved Amniotic Membranes
        • Dehydrated Amniotic Membranes
        • Amniotic Suspensions
      • By Application:
        • Wound Care
        • Orthopedics
        • Ophthalmology
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Specialty Clinics
        • Research and Academic Institutes
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Amniotic Membranes
        • Cryopreserved Amniotic Membranes
        • Dehydrated Amniotic Membranes
        • Amniotic Suspensions
      • By Application:
        • Wound Care
        • Orthopedics
        • Ophthalmology
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Specialty Clinics
        • Research and Academic Institutes
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Amniotic Membranes
        • Cryopreserved Amniotic Membranes
        • Dehydrated Amniotic Membranes
        • Amniotic Suspensions
      • By Application:
        • Wound Care
        • Orthopedics
        • Ophthalmology
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Specialty Clinics
        • Research and Academic Institutes
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Amniotic Membranes
        • Cryopreserved Amniotic Membranes
        • Dehydrated Amniotic Membranes
        • Amniotic Suspensions
      • By Application:
        • Wound Care
        • Orthopedics
        • Ophthalmology
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Specialty Clinics
        • Research and Academic Institutes
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Amniotic Membranes
        • Cryopreserved Amniotic Membranes
        • Dehydrated Amniotic Membranes
        • Amniotic Suspensions
      • By Application:
        • Wound Care
        • Orthopedics
        • Ophthalmology
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Specialty Clinics
        • Research and Academic Institutes
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Amniotic Membranes
        • Cryopreserved Amniotic Membranes
        • Dehydrated Amniotic Membranes
        • Amniotic Suspensions
      • By Application:
        • Wound Care
        • Orthopedics
        • Ophthalmology
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Specialty Clinics
        • Research and Academic Institutes
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Smith & Nephew*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Applied Biologics
    • Organogenesis Holdings Inc.
    • Osiris Therapeutics, Inc.
    • Alliqua BioMedical, Inc.
    • Amnio Technology, LLC
    • Next Biosciences
    • Integra LifeSciences
    • MiMedx
    • LifeCell International
    • Human Regenerative Technologies, LLC
    • Amniox Medical, Inc.
    • Skye Biologics Inc.
    • Wright Medical
    • TissueTech
    • Katena Products, Inc.
    • NuVision Biotherapies
    • Surgenex
    • Ventris Medical

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Porter’s Analysis
    • Industry Trends
    • Key Highlights
    • Epidemiology
    • Reimbursement Scenario of Amniotic Membranes
    • Regulatory Scenario
    • Product Launch and Approvals
    • Acquisition and Collaboration Scenario
  4.  Global Amniotic Membrane Market - Impact of Coronavirus (Covid-19) Pandemic
    • COVID-19 Epidemiology
    • Impact of COVID-19 on Demand and Supply of Amniotic Membranes
    • Impact of COVID-19 on the overall Healthcare Sector
  5. Global Amniotic Membrane Market, By Product Type, 2017-2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Amniotic Membranes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Cryopreserved Amniotic Membranes    
    • Dehydrated Amniotic Membranes
    • Amniotic Suspensions
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  6. Global Amniotic Membrane Market, By Application, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Wound Care
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Orthopedics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Ophthalmology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  7. Global Amniotic Membrane Market, By End User, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Specialty Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
    • Research and Academic Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  8. Global Amniotic Membrane Market, By Region, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018 - 2028
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Company Profiles
      • Smith & Nephew*
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Applied Biologics
      • Organogenesis Holdings Inc.
      • Osiris Therapeutics, Inc.
      • Alliqua BioMedical, Inc.
      • Amnio Technology, LLC
      • Next Biosciences
      • Integra LifeSciences
      • MiMedx
      • LifeCell International
      • Human Regenerative Technologies, LLC
      • Amniox Medical, Inc.
      • Skye Biologics Inc.
      • Wright Medical
      • TissueTech
      • Katena Products, Inc.
      • NuVision Biotherapies
      • Surgenex
      • Ventris Medical

*Key pointers provided are also applicable to other companies covered in the scope of the report.

  • Analyst Views
  1. Section
    • Research Methodology
    • About us
    • Contact

*Browse 33 market data tables and 25 figures on "Amniotic Membrane Market” - Global Forecast to 2028.

FAQgrowicon

Frequently Asked Questions

The global amniotic membrane market is expected to exhibit a CAGR of 12.8% during the forecast period (2021-2028).
The market is estimated to be valued at US$ 3,201.1 Mn in 2021.
Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical are some of the prominent players operating in the market.
The market is expected to be valued at US$ 7,438.2 Mn in 2028.
North America is the prominent region in the market.
Increasing number of product launches, rising cases of ophthalmology surgeries, increasing research and development activities by the market players, and increasing strategic collaborations among the market players are some of the driving factors, which are expected to drive growth of the market.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner